|
The clinical effect of recombinant tissue plasminogen activator on prevention of thrombokinesis in tunneled cuffed catheter
2016, 15 (01):
51-54.
doi: 10.3969/j.issn.1671-4091.2016.01.014
Objective To explore the clinical effect of recombinant tissue plasminogen activator (rt-PA) on the prevention of thrombokinesis in tunneled cuffed catheter (TCC). Methods A total of 62 cases of maintenance hemodialysis patients were randomly divided into control group, urokinase group, and rt- PA group. The difficulties of blood access before dialysis, the intervention rate during dialysis, blood flow volume, venous pressure, and other complications were compared among the 3 groups. Results The difficulties of blood access before dialysis, the intervention rate during dialysis, and venous pressure were lower in rt-PA
group than in urokinase group (5.1% vs. 10.7%, χ2=58.643, P=0.000 for difficulties of blood access before dialysis; 5.8% vs. 11.0%, χ2=48.027, P=0.000 for intervention rate during dialysis; 113.0±14.1 mmHg vs. 123.0±14.4 mmHg, q=3.154, P=0.037 for venous pressure) and control group (5.1% vs. 13.7%, χ2= 115.387, P=0.000 for difficulties of blood access before dialysis; 5.8% vs. 17.8%, χ2=187.411, P=0.000 for intervention rate during dialysis; 113.0±14.1 mmHg vs. 135.2±15.1 mmHg, q=6.854, P=0.005 for venous pressure). These parameters were also lower in urokinase group than in control group (P<0.05). Blood flow volume was higher in rt-PA group than in urokinase group (248.1±14.9 ml/min vs. 239.1±14.2 ml/min, q=2.906, P=0.042) and control group (248.1±14.9 ml/min vs. 227.9±13.4 ml/min, q=6.378, P=0.006), and was higher in urokinase group than in control group (q=3.508, P<0.05). The rates of bleeding and infection were similar among the 3 groups (χ2=0.233, P=0.890 for bleeding; χ2=1.541, P=0.463 for infection). Conclusion In addition to heparin, regular
use of rt-PA for blocking TCC can safely and effectively prevent thrombokinesis in TCC and increase dialysis blood volume.
Metrics
|